Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yuka Kobara"'
Autor:
Akari Nagamine, Hiroshi Hasegawa, Naoko Hashimoto, Tomoko Yamada-Inagawa, Masanori Hirose, Yuka Kobara, Hiroyuki Tadokoro, Yoshio Kobayashi, Hiroyuki Takano
Publikováno v:
Journal of Pharmacological Sciences, Vol 133, Iss 1, Pp 42-48 (2017)
Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral hypoglycemic agents for patients with type 2 diabetes mellitus and have potential antiatherosclerotic properties. Meanwhile, it is unclear how DPP-4 inhibitors have protective effects
Externí odkaz:
https://doaj.org/article/a7aace2edf7542c59aa801212660c9e4
Publikováno v:
International Heart Journal. 59:1303-1311
Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used as antidiabetic drugs. We recently reported that DPP-4 inhibition has beneficial effects on heart failure (HF) mice model. Furthermore, we confirmed that myocardial DPP-4 activity was signific
Autor:
Masanori Hirose, Yuka Kobara, Hiroyuki Tadokoro, Akari Nagamine, Tomoko Yamada-Inagawa, Naoko Hashimoto, Hiroyuki Takano, Hiroshi Hasegawa, Yoshio Kobayashi
Publikováno v:
Journal of Pharmacological Sciences, Vol 133, Iss 1, Pp 42-48 (2017)
Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral hypoglycemic agents for patients with type 2 diabetes mellitus and have potential antiatherosclerotic properties. Meanwhile, it is unclear how DPP-4 inhibitors have protective effects
Autor:
Yoshio Kobayashi, Akihiko Kubota, Issei Komuro, Hiroyuki Takano, Tomoko Yamada-Inagawa, Hiroyuki Tadokoro, Hiroshi Hasegawa, Haixiu Wang, Yuka Kobara, Masanori Hirose
Publikováno v:
Journal of Molecular and Cellular Cardiology. 91:72-80
Aims Dipeptidyl peptidase-4 (DPP-4) inhibitors are reported to have protective effects on various cells but it is unclear how DPP-4 inhibitors have cardioprotective effects. Our aim was to study the mechanisms of cardioprotective effects by DPP-4 inh
Autor:
Hiroshi Hasegawa, Yuka Kobara, N Yamaguchi, Masanori Hirose, Hiroyuki Takano, Yoshio Kobayashi
Publikováno v:
European Heart Journal. 39
Autor:
Yuka Kobara, Hiroshi Hasegawa, Tomoko Yamada-Inagawa, Akihiko Kubota, Yoshio Kobayashi, Masanori Hirose, Hiroyuki Tadokoro, Genzou Takemura, Hiroyuki Takano
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 80(9)
Background Inflammatory responses, especially by CD4(+)T cells activated by dendritic cells, are known to be important in the pathophysiology of cardiac repair after myocardial infarction (MI). Although co-stimulatory signals through B7 (CD80/86) and
Autor:
Genzou Takemura, Hiroyuki Tadokoro, Yuka Kobara, Yoshio Kobayashi, Masanori Hirose, Hiroshi Hasegawa, Hiroyuki Takano
Publikováno v:
Journal of Cardiac Failure. 22:S205
Autor:
Hiroyuki Tadokoro, Yuka Kobara, Hiroshi Hasegawa, Hiroyuki Takano, Yoshihito Kameda, Akihiko Kubota, Yoshio Kobayashi, Issei Komuro
Publikováno v:
Journal of Cardiac Failure. 18:S179-S180
Autor:
Akihiko Kubota, Yuka Kobara, Masanori Hirose, Hiroyuki Tadokoro, Yoshio Kobayashi, Issei Komuro, Hiroyuki Takano, Yoshihito Kameda, Hiroshi Hasegawa
Publikováno v:
European Heart Journal. 34:P3305-P3305
Background: Dipeptidyl peptidase-4 (DPP-4) inhibitors are newly available drugs for diabetes mellitus, but it is unclear whether DPP-4 inhibitors have cardioprotective effects or not. Methods: C57BL/6 mice and DPP-4 knockout (DPP-4-/-) mice were subj
Autor:
Yoshio Kobayashi, Issei Komuro, Yuka Kobara, Hiroyuki Tadokoro, Hiroyuki Takano, Yoshihito Kameda, Akihiko Kubota, Hiroshi Hasegawa
Publikováno v:
Journal of Cardiac Failure. 18:S157